Beyblade X introduces older characters competing professionally with a new design and faster gameplay mechanics. Executive ...

Get ready to Let It Rip! Our writer sat down with the legendary animation director, Katsuhito Akiyama, to talk about his role as Executive Director of the new BEYBLADE X animation series. Since ...

Nishi explained that, “No other characters feel as ‘alive’ as she does—always acting unpredictably and freely. I enjoy writing for her because she’s almost always up to something strange ...

Want to know about new Genshin Impact characters? During each new update, there’s usually at least one brand-new playable character introduced to the roster. They typically appear on event ...

Which characters are in 2XKO? Predicting the final roster isn’t as easy to do with the League of Legends spinoff. After all, there are over 140 potential Champions to pick from. Equipped with a ...

Oda has gone on record in his SBS column that the loss of a protector forces the characters to grow, explaining why so few characters have mothers. While some fans agree that this is a narrative ...

AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of “aa-” (Superior) of The Dai-ichi Life Insurance Company, Limited (DL) (Japan), the ...

HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A+ (Superior) and the Long-Term Issuer Credit Rating of “aa-” (Superior) of The Dai-ichi Life Insurance ...

PETALING JAYA: The tussle between IHH Healthcare Bhd, Asia’s biggest private healthcare provider, and Daiichi Sankyo Co Ltd, a pharmaceutical firm, over IHH’s open offer for the 26% of shares ...

Dai-Ichi Karkare Limited (DIKL) was set up in 1960 as a private limited company for the manufacture of speciality chemicals. The Company entered into technical collaboration with the ...

Disclaimer: This article has been developed and funded by Daiichi Sankyo. Daiichi Sankyo has more than 120 years of experience and scientific expertise. In 2019, they entered the oncology market ...